Preferred Label : eplontersen;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3638357/fr/wainzua-eplontersen-amylose-hereditaire-a-transthyretine-avec-polyneuropathie
2025
France
evaluation of the transparency committee
eplontersen
amylose
polyneuropathies
eplontersen
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, nos
prealbumin
polyneuropathy, nos
amyloid deposition, nos
prealbumin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/wainzua
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
eplontersen
eplontersen
drug approval
europe
eplontersen
amyloidosis, hereditary, Transthyretin-Related
adult
injections, subcutaneous
oligonucleotides, antisense
oligonucleotides, antisense
risk management
eplontersen sodium
eplontersen sodium
product surveillance, postmarketing
pregnancy
breast feeding
Female of Childbearing Potential
drug evaluation, preclinical

---
Nous contacter.
17/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.